Literature DB >> 21790266

Reconceptualizing medication adherence: six phases of dynamic adherence.

Robin E Gearing1, Lisa Townsend, Michael MacKenzie, Alice Charach.   

Abstract

Nonadherence is the Achilles' heel of effective psychiatric treatment. It affects the resolution of mental health symptoms and interferes with the assessment of treatment response. The meaning of the term adherence has evolved over time and is now associated with a variety of definitions and measurement methods. The result has been a poorly operationalized and nonstandardized term that is often interpreted differently by providers and patients. Drawing extensively from the literature, this article aims to (1) describe changes in the concept of adherence, drawing from the mental health treatment literature, (2) present a more comprehensive definition of adherence that recognizes the role of patient-provider transactions, (3) introduce dynamic adherence, a six-phase model, which incorporates the role of transactional processes and other factors that influence patients' adherence decisions, and (4) provide recommendations for providers to improve adherence as well as their relationships with patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21790266     DOI: 10.3109/10673229.2011.602560

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  12 in total

1.  Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.

Authors:  Daniel J Coletti; Elizabeth Pappadopulos; Nikki J Katsiotas; Alison Berest; Peter S Jensen; Vivian Kafantaris
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-04-26       Impact factor: 2.576

2.  How do we better translate adherence research into improvements in patient care?

Authors:  Adam La Caze; Gina Gujral; William Neil Cottrell
Journal:  Int J Clin Pharm       Date:  2014-02

Review 3.  What are validated self-report adherence scales really measuring?: a systematic review.

Authors:  Thi-My-Uyen Nguyen; Adam La Caze; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

Review 4.  State of the science of adherence in pre-exposure prophylaxis and microbicide trials.

Authors:  Felix M Muchomba; Robin E Gearing; Jane M Simoni; Nabila El-Bassel
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

Review 5.  Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder?

Authors:  Joshua M Langberg; Stephen P Becker
Journal:  Clin Child Fam Psychol Rev       Date:  2012-09

6.  Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol.

Authors:  Katherine A Yeager; Drenna Waldrop-Valverde; Sudeshna Paul; Deborah Watkins Bruner; Rebecca Klisovic; Emily Burns; Tamara A Mason; Nisha Patel; Bonnie Mowinski Jennings
Journal:  Res Nurs Health       Date:  2020-08-31       Impact factor: 2.228

7.  Perceptions of ADHD Among Diagnosed Children and Their Parents: A Systematic Review Using the Common-Sense Model of Illness Representations.

Authors:  Iana Y T Wong; David J Hawes; Simon Clarke; Michael R Kohn; Ilan Dar-Nimrod
Journal:  Clin Child Fam Psychol Rev       Date:  2018-03

8.  Long-Run Trends in Antidepressant Use Among Youths After the FDA Black Box Warning.

Authors:  Nilay Kafali; Ana Progovac; Sherry Shu-Yeu Hou; Benjamin Lê Cook
Journal:  Psychiatr Serv       Date:  2017-12-15       Impact factor: 3.084

Review 9.  Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care.

Authors:  Wai Tong Chien; Sau Fong Leung; Frederick Kk Yeung; Wai Kit Wong
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-25       Impact factor: 2.570

Review 10.  Enhancing ADHD medication adherence: challenges and opportunities.

Authors:  Alice Charach; Rebeca Fernandez
Journal:  Curr Psychiatry Rep       Date:  2013-07       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.